Reuters logo
BRIEF-DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET
November 2, 2017 / 4:45 PM / 17 days ago

BRIEF-DR. REDDY'S LABORATORIES LAUNCHES GENERIC AZACITIDINE FOR INJECTION IN CANADIAN MARKET

Nov 2 (Reuters) - Dr.Reddy’s Laboratories Ltd

* DR REDDY‘S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET

* GENERIC AZACITIDINE FOR INJECTION 100 MG/VIAL, A BIOEQUIVALENT GENERIC VERSION OF VIDAZA IS APPROVED BY HEALTH CANADA​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below